MTOR and breast carcinoma: Moreover, UCA1 has been implicated in hormone therapy resistance in breast cancer cells as it sponges miR-18a, leading to HIF1α activation or inhibition of mTOR signaling (48, 49), suggesting its multiple functions in breast cancer metabolism.